DZ Bank AG reaffirmed their sell rating on shares of STADA ARZNEIMITTEL NPV(REGD) (VINKULIERT) (NASDAQ:STDAF) in a research note issued to investors on Thursday.
STADA ARZNEIMITTEL NP (NASDAQ STDAF) remained flat at $$93.75 during trading on Thursday. STADA ARZNEIMITTEL NP has a one year low of $45.80 and a one year high of $97.45.
TRADEMARK VIOLATION WARNING: “STADA ARZNEIMITTEL NPV(REGD) (VINKULIERT) (STDAF) Given “Sell” Rating at DZ Bank AG” was first published by Markets Daily and is owned by of Markets Daily. If you are reading this article on another domain, it was copied illegally and reposted in violation of United States and international trademark and copyright legislation. The legal version of this article can be read at https://www.themarketsdaily.com/2017/11/12/stada-arzneimittel-npvregd-vinkuliert-stdaf-given-sell-rating-at-dz-bank-ag.html.
Receive News & Ratings for STADA ARZNEIMITTEL NPV(REGD) (VINKULIERT) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STADA ARZNEIMITTEL NPV(REGD) (VINKULIERT) and related companies with MarketBeat.com's FREE daily email newsletter.